Catégories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
DL-Tartaric acid
(20981132 | 133-37-9)
CAS: | 133-37-9 |
---|---|
Formule moléculaire: | C4H6O6 |
Masse moléculaire: | 150.09 |
Disponibilité: | En stock |
---|---|
Téléchargements: | | |
20981132-500g | 500g | £54.50 | |
Commande en vrac |
20981132-500g | 500g | €76.30 | |
Commande en vrac |
20981132-500g | 500g | $81.80 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 20981132 | ||||
Product Name | DL-Tartaric acid | ||||
Categories | Building Blocks Chiral Compounds Flavours and Fragrance Materials Organics | ||||
CAS | 133-37-9 | ||||
Molecular Formula | C4H6O6 | ||||
Molecular Weight | 150.09 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 29181200 |
Spécifications du produit
Melting Point | 200-206°C | ||||
Arsenic | ≤0.0002% | ||||
Loss on Drying | ≤0.5% | ||||
Sulfate | ≤0.04% | ||||
Residue on Ignition | ≤0.1% | ||||
Content | ≥98.5% | ||||
Heavy Metal | ≤0.001% | ||||
Description | white crystalline powder | ||||
Oxidabel matter | Passed |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|